123 related articles for article (PubMed ID: 7053705)
1. Hepatic veno-occlusive disease caused by 6-thioguanine.
Gill RA; Onstad GR; Cardamone JM; Maneval DC; Sumner HW
Ann Intern Med; 1982 Jan; 96(1):58-60. PubMed ID: 7053705
[TBL] [Abstract][Full Text] [Related]
2. 6-thioguanine as a cause of toxic veno-occlusive disease of the liver.
Satti MB; Weinbren K; Gordon-Smith EC
J Clin Pathol; 1982 Oct; 35(10):1086-91. PubMed ID: 6957419
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.
Griner PF; Elbadawi A; Packman CH
Ann Intern Med; 1976 Nov; 85(5):578-82. PubMed ID: 1068643
[TBL] [Abstract][Full Text] [Related]
4. Peliosis hepatis induced by 6-thioguanine administration.
Larrey D; Fréneaux E; Berson A; Babany G; Degott C; Valla D; Pessayre D; Benhamou JP
Gut; 1988 Sep; 29(9):1265-9. PubMed ID: 3198003
[TBL] [Abstract][Full Text] [Related]
5. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
[TBL] [Abstract][Full Text] [Related]
6. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
[TBL] [Abstract][Full Text] [Related]
7. Reversible hepatic veno-occlusive disease and 6-thioguanine.
Krivoy N; Raz R; Carter A; Alroy G
Ann Intern Med; 1982 Jun; 96(6 Pt 1):788. PubMed ID: 7091946
[No Abstract] [Full Text] [Related]
8. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
[TBL] [Abstract][Full Text] [Related]
9. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.
Wang X; Kanel GC; DeLeve LD
Hepatology; 2000 Feb; 31(2):428-34. PubMed ID: 10655267
[TBL] [Abstract][Full Text] [Related]
10. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
Kane S; Cohen SM; Hart J
Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
[TBL] [Abstract][Full Text] [Related]
11. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases.
Goodman ZD; Ishak KG
Gastroenterology; 1982 Oct; 83(4):786-96. PubMed ID: 7106509
[TBL] [Abstract][Full Text] [Related]
12. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease.
Geller SA; Dubinsky MC; Poordad FF; Vasiliauskas EA; Cohen AH; Abreu MT; Tran T; Martin P; Vierling JM; Targan SR
Am J Surg Pathol; 2004 Sep; 28(9):1204-11. PubMed ID: 15316320
[TBL] [Abstract][Full Text] [Related]
13. A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity.
Oancea I; Png CW; Das I; Lourie R; Winkler IG; Eri R; Subramaniam N; Jinnah HA; McWhinney BC; Levesque JP; McGuckin MA; Duley JA; Florin TH
Gut; 2013 Apr; 62(4):594-605. PubMed ID: 22773547
[TBL] [Abstract][Full Text] [Related]
14. MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
Marasco G; Scaioli E; Renzulli M; Colecchia A; Golfieri R; Festi D; Bazzoli F; Digby RJ; Belluzzi A
Am J Gastroenterol; 2016 Jun; 111(6):767. PubMed ID: 27249976
[No Abstract] [Full Text] [Related]
15. [Clinical characteristics of hepatic veno-occlusive disease in 6 children with hematologic neoplasm treated with 6-thioguanine].
Wang HS; Gao YJ; Li J; Lu FJ; Miao H; Qian XW; Zhu XF
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):708-10. PubMed ID: 21092535
[TBL] [Abstract][Full Text] [Related]
16. [Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children].
Mao JQ; Zhao FY; Song H; Yang SL; Shen DY; Tang YM
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):788-90. PubMed ID: 24034928
[No Abstract] [Full Text] [Related]
17. 6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease.
Kao NL; Rosenblate HJ
J Am Acad Dermatol; 1993 Jun; 28(6):1017-8. PubMed ID: 8496447
[No Abstract] [Full Text] [Related]
18. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study.
Burt AD; MacSween RN
J Clin Pathol; 1986 Jan; 39(1):63-7. PubMed ID: 3950032
[TBL] [Abstract][Full Text] [Related]
19. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
Read AE; Wiesner RH; LaBrecque DR; Tifft JG; Mullen KD; Sheer RL; Petrelli M; Ricanati ES; McCullough AJ
Ann Intern Med; 1986 May; 104(5):651-5. PubMed ID: 3008617
[TBL] [Abstract][Full Text] [Related]
20. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
